Cerrahi Hastalarda Venöz Tromboembolizm ve Kanıta Dayalı Hemşirelik Uygulamaları

Centers for Disease Control and Prevention. Venous thromboembolism (blood clots). 2016. (20\04\2024 tarihinde http://www.cdc.gov/ncbddd/dvt/facts.html adresinden ulaşılmıştır.)
Türk Toraks Derneği Pulmoner Tromboembolizm Tanı Ve Tedavi Uzlaşı Raporu, 2021. (20\04\2024 tarihinde https://toraks.org.tr/site/sf/books/2021/06/c0eefce4d5d10929930f7f1abd7b2e48055dac42e01827898a08ec0ee4e961e7.pdf adresinden ulaşılmıştır.
Kakkos SK, Gohel M, Baekgaard N, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9-82. doi:10.1016/j.ejvs.2020.09.023
Phillippe HM. Overview of venous thromboembolism. Am J Manag Care. 2017;23(20 Suppl): S376-S382.
López, JA, Chen J. Pathophysiology of venous thrombosis. Thrombosis research, 2009; 123, S30-S34.
Karadağ M, Bulut H. Surgical nursing. First ed. Ankara: Visa Publishing; 2019.
Gould MK, Garcia DA, Wren SM, et al. Prevention of vte in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012; 141(2 suppl): e227S-e277S.
Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Klavuzu. 2010. (10\03\2024 tarihinde https://file.tkd.org.tr/kilavuzlar/ulusal/2010_ulusal_venoz_tromboe mbolizm_profilaksi_tedavi_kilavuzu.pdf adresinden ulaşılmıştır.)
Al-Mugheed KA, Bayraktar N. Knowledge and practices of nurses on deep vein thrombosis risks and prophylaxis: A descriptive cross sectional study [published correction appears in J Vasc Nurs. 2021 Mar;39(1):25]. J Vasc Nurs. 2018;36(2):71-80. doi: 10.1016/j.jvn.2018.02.001
Darzi AJ, Karam SG, Charide R, et al. Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020;135(20):1788-1810. doi:10.1182/blood.2019003603
Zhai Z, Kan Q, Li W, et al. VTE risk profiles and prophylaxis in medical and surgical ınpatients: the ıdentification of chinese hospitalized patients' risk profile for venous thromboembolism (dissolve-2)-a cross-sectional study. Chest. 2019;155(1):114-122. doi:10.1016/j.chest.2018.09.020
Martinelli I., Bucciarelli P., Mannucci P.M. Thrombotic risk factors: basic pathophysiology. Crit. Care Med. 2010;38: S3–S9. doi: 10.1097/CCM.0b013e3181c9cbd9.
Pastori D, Cormaci VM, Marucci S, et al. A Comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24(4):3169. Published 2023 Feb 5. doi:10.3390/ijms24043169
Ramli NN, Iberahim S, Mohd Noor NH, et al. Haemostasis and ınflammatory parameters as potential diagnostic biomarkers for vte in trauma-ımmobilized patients. diagnostics (basel). 2023;13(1):150. Published 2023 Jan 2. doi:10.3390/diagnostics13010150
Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res. 2020; 187:103-112. doi:10.1016/j.thromres.2020.01.017
Tana C, Lauretani F, Ticinesi A, Prati B, Nouvenne A, Meschi T. Molecular and clinical ıssues about the risk of venous thromboembolism in older patients: a focus on parkinson's disease and parkinsonism. Int J Mol Sci. 2018;19(5):1299. doi:10.3390/ijms19051299
Ferrazzini E, Méan M, Stalder O, Limacher A, Rodondi N, Aujesky D. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism. Blood Adv. 2023;7(2):205-213. doi:10.1182/bloodadvances.2022007263
Türkiye İstatistik Kurumu. 2023. (10\03|2024 tarihinde https://data.tuik.gov.tr/Bulten/Index?p=Adrese-Dayal%C4%B1-N%C3%BCfus-Kay%C4%B1t-Sistemi-Sonu%C3%A7lar%C4%B1-2023-49684&dil=1 adresinden ulaşılmıştır.)
Darvall K.A., Sam R.C., Silverman S.H., Bradbury A.W., Adam D.J. obesity and thrombosis. Eur. J. Vasc. Endovasc. Surg. 2007;33:223–233. doi: 10.1016/j.ejvs.2006.10.006.
Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: asco clinical practice guideline update. J Clin Oncol. 2020;38(5):496-520. doi:10.1200/JCO.19.01461
Kim AS, Khorana AA, McCrae KR. Mechanisms and biomarkers of cancer-associated thrombosis. Transl Res. 2020;225:33-53. doi:10.1016/j.trsl.2020.06.012
Yorkgitis BK, Berndtson AE, Cross A, et al. American association for the surgery of trauma/american college of surgeons-committee on trauma clinical protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute Care Surg. 2022;92(3):597-604. doi:10.1097/TA.0000000000003475
Áinle FN, Kevane B. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?. Hematology Am Soc Hematol Educ Program. 2020;2020(1):201-212. doi:10.1182/hematology.2020002268
Connors J.M. Thrombophilia Testing and Venous Thrombosis. N. Engl. J. Med. 2017; 377:1177–1187. doi: 10.1056/NEJMra1700365.
Dicks AB, Moussallem E, Stanbro M, Walls J, Gandhi S, Gray BH. A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism. J Clin Med. 2024;13(2):362. Published 2024 Jan 9. doi:10.3390/jcm13020362
Lobbes H, Mainbourg S, Mai V, Douplat M, Provencher S, Lega JC. Risk factors for venous thromboembolism in severe covıd-19: a study-level meta-analysis of 21 studies. Int J Environ Res Public Health. 2021;18(24):12944. doi:10.3390/ijerph182412944
De Barros VIPVL, de Oliveira ALML, do Nascimento DJ, et al. Use of hormones and risk of venous thromboembolism. Rev Bras Ginecol Obstet. 2024;46: e-FPS02. doi:10.61622/rbgo/2024FPS02
Edebiri O, Ní Áinle F. Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy. Breathe (Sheff). 2022;18(2):220018. doi:10.1183/20734735.0018-2022
Kim KA, Choi SY, Kim R. Endovascular treatment for lower extremity deep vein thrombosis: an overview. Korean J Radiol. 2021;22(6):931-943. doi:10.3348/kjr.2020.0675
Bosch FTM, Nisio MD, Büller HR, van Es N. Diagnostic and therapeutic management of upper extremity deep vein thrombosis. J Clin Med. 2020;9(7):2069. doi:10.3390/jcm9072069
Ružičić DP, Dzudovic B, Matijasevic J, et al. Signs and symptoms of acute pulmonary embolism and their predictive value for all-cause hospital death in respect of severity of the disease, age, sex and body mass index: retrospective analysis of the Regional PE Registry (REPER). BMJ Open Respir Res. 2023;10(1):e001559. doi:10.1136/bmjresp-2022-001559
Potter PA, Perry AG, Stockert PA, Hall AM. Fundamentals of nursing. 9th ed. e-Book: Elsevier, 2016
Aslan Eti F. Cerrahi bakım. İkinci Baskı. Ankara. Akademisyen Yayınevi; 2017
Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of dvt: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e351S-e418S. doi:10.1378/chest.11-2299
Autar R. The management of deep vein thrombosis: the autar dvt risk assessment scale re-visited. Journal of Orth Nurs 2003; 7(3): 114–124. doi: 10.1016/S1361-3111(03)00051-7
Speth J. Guidelines in practice: prevention of venous thromboembolism. AORN J. 2023;118(5):321-328. doi:10.1002/aorn.14019
Holford NH. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet. 1986;11(6):483-504. doi:10.2165/00003088-198611060-00005
Foerster KI, Hermann S, Mikus G, Haefeli WE. Drug-Drug ınteractions with direct oral anticoagulants [published correction appears in clin pharmacokinet. Clin Pharmacokinet. 2020;59(8):967-980. doi:10.1007/s40262-020-00879-x
Oertel LB. Heparin consensus group. unfractionated heparin: a nursing dilemma. Pharmacotherapy. 2004;24(8):156S-160S. doi:10.1592/phco.24.12.156s.36111
Vayne C, Hardion S, Guery EA, Pouplard C. Utilisation des héparines et dérivés lors de soins infirmiers [Use of heparin and its derivatives in nursing care]. Soins. 2016;(803):23-28. doi:10.1016/j.soin.2015.10.026
Zabolotskikh IB, Sin'kov SV, Klevko VA. Nizkomolekuliarnyĭ geparin -- énoksaparin (kleksan) v profilaktike tromboémbolicheskikh oslozhneniĭ khirurgicheskikh bol'nykh [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients]. Anesteziol Reanimatol. 2001;(2):70-75.
McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial. J Thromb Haemost. 2020;18(2):411-421. doi:10.1111/jth.14662
Li X, Haddadin I, McLennan G, et al. Inferior vena cava filter - comprehensive overview of current indications, techniques, complications and retrieval rates. Vasa. 2020;49(6):449-462. doi:10.1024/0301-1526/a000887
Wang J, Smeath E, Lim HY, Nandurkar H, Kok HK, Ho P. Current challenges in the prevention and management of post-thrombotic syndrome-towards improved prevention. Int J Hematol. 2023;118(5):547-567. doi:10.1007/s12185-023-03651-6
Appelen D, van Loo E, Prins MH, Neumann MH, Kolbach DN. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2017;9(9):CD004174. doi:10.1002/14651858.CD004174.pub3
Yandrapalli S, Tariq S, Kumar J, et al. Chronic thromboembolic pulmonary hypertension: epidemiology, diagnosis, and management. Cardiol Rev. 2018;26(2):62-72. doi:10.1097/CRD.0000000000000164
Mullin CJ, Klinger JR. Chronic thromboembolic pulmonary hypertension. heart Fail Clin. 2018;14(3):339-351. doi:10.1016/j.hfc.2018.02.009
Barrow S, Cherry C, Hickey C, Kelly KS. Pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. AORN J. 2005;82(4):604-628. doi:10.1016/s0001-2092(06)60030-6
Croke L. Guideline for prevention of venous thromboembolism. AORN journal. 2022;116(6), P4–P6. https://doi.org/10.1002/aorn.13839
Speth J. Guidelines in practice: prevention of venous thromboembolism. AORN journal, 2023;118(5),321–328. https://doi.org/10.1002/aorn.14019
Centers for Disease Control and Prevention (CDC). Venous thromboembolism (blood clots). 2023. (01\03\2024 tarihinde https://www.cdc.gov/ncbddd/dvt/index.html adresinden ulaşılmıştır)
National Institute for Health and Care Excellence. Venous Thromboembolism in Over 16s: Reducing the Risk of Hospital-Acquired Deep Vein Thrombosis or Pulmonary Embolism. NICE guideline. 2018 ( 01.04.2024 tarihinde https://www.nice.org.uk/guidance/ng89/resources/venous-thromboembolism-in-over-16s-reducing-the-risk-of-hospitalacquired-deep-vein-thrombosis-or-pulmonary-embolism-pdf-1837703092165 adresinden ulaşılmıştır.)
Link T. Guideline ımplementation: prevention of venous thromboembolism. AORN journal, 2023; 107(6), 737-748. (01\04\2024 tarihinde https://aornjournal.onlinelibrary.wiley.com/doi/abs/10.1002/aorn.12146 adresinden ulaşılmıştır.)
Denver CO. Guideline for prevention of venous thromboembolism. In: guidelines for perioperative practice, 2023 AORN journal,in press.
Bartlett MA, Mauck KF, Stephenson CR, Ganesh R, Daniels PR. Perioperative venous thromboembolism prophylaxis. Mayo Clinic, 2020; 95(12):2775-2798. doi:10.1016/j.mayocp.2020.06.015
Denver C.O.Guideline for team communication. In: Guidelines for Perioperative Practice.AORN journal, 2022; 118(6), 1155-1186.
Larkin BG, Mitchell KM, Petrie K. Translating evidence to practice for mechanical venous thromboembolism prophylaxis. AORN journal, 2012; 96(5), 513–527. https://doi.org/10.1016/j.aorn.2012.07.011
Sharon A. Prevention of venous thromboembolism. AORN journal, 2014; 99(5), 642-647. https://doi.org/10.1016/j.aorn.2014.02.001
Venous thromboembolism in adults: reducing the risk in hospital. National Institute for Health and Care Excellence (NICE), 2010. ( 01\04\2024 tarihinde https://www.nice.org.uk/guidance/QS3 adresinden ulaşılmıştır.)
Key Takeaways: 6 critical guideline updates to prevent of venous thromboembolism (VTE). AORN. 2023. (20\04\2024 tarihinde https://www.aorn.org/article/key-takeaways-6-critical-guideline-updates-to-prevent-vte adresinden ulaşılmıştır).